Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45

Overview of attention for article published in Annals of Neurology, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 8 X users
patent: 3 patents

facebook: 8 Facebook pages

Readers on

mendeley: 101 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 101,260 followers.

When CureDuchenne first funded Prosensa 11 years ago, the original plan was to develop an exon 46 skipping drug... http://t.co/bgQVuBD3NX

Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. - PubMed - NCBI http://t.co/PxJRaxUmnR

http://t.co/2OrEwyggnJ http://t.co/gv6UOgnI2N

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.